NCT00083668View on ClinicalTrials.gov

Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

619

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

May 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00083668 - Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia | Biotech Hunter | Biotech Hunter